Advances in qPCR and dPCR

Select Biosciences South East Asia is pleased to present Advances in qPCR and dPCR.

Having successfully run the event in Boston, USA, Frankfurt, Germany, Daejeon, Korea and
Barcelona, Spain, we look forward to bringing the meeting to Singapore.

The event will take place on the 21-22 May 2015.

We will be focusing on new developments in qPCR technology, concentrating on improvements to
qPCR design, the acquisition of accurate data, and efficient data analysis. Particular emphasis will
also be given to the use of qPCR in Cancer diagnosis.

Focus will also be given to the use of dPCR in the clinic, covering applications such as infectious
disease diagnostics and cancer detection. Another important area for discussion will be the
applications for forensics and anti-terrorism.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers,
helping you to find unique solutions and build long term collaborations.

Keynote Speakers
Fred Kramer - Professor, New Jersey Medical School, Rutgers University, USA
Mikael Kubista - Professor/Founder, TATAA Biocenter, Sweden

Agenda Topics
• Bioinformatics and Data Analysis
• Clinical Applications of Digital PCR
• Diagnosing Cancer with qPCR
• Forensics and Anti-terrorism Uses
• Mutation Analysis
• New Developments in Digital PCR
• New qPCR Approaches
• PLA - Proximity Ligation Assays
• qPCR in Diagnostics
• Single Cell Analysis
• Standardisation & Validation

Media Contact
Paul Raggett, CEO
Select Biosciences South East Asia Pte. Ltd.
16 Raffles Quay, #33-03 Hong Leong Building,
Singapore 048581
Tel: +65 9186 3246
Email: [email protected]

From 21 May 2015
Until 22 May 2015
News topics: